CN Patent

CN114805202A — 苯磺酰胺类化合物及其制备方法和应用

Assigned to Shanghai Jiyu Pharmaceutical Technology Co ltd · Expires 2022-07-29 · 4y expired

What this patent protects

本发明公开了苯磺酰胺类化合物及其制备方法和应用，具体地，本发明公开了式(Ⅰ)所示化合物及其药效上可接受的盐，及其用于慢性肾病的治疗。

USPTO Abstract

本发明公开了苯磺酰胺类化合物及其制备方法和应用，具体地，本发明公开了式(Ⅰ)所示化合物及其药效上可接受的盐，及其用于慢性肾病的治疗。

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: CN114805202A
Jurisdiction: CN
Classification: —
Expires: 2022-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Jiyu Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.